Selected Assignments

• Led start-up biopharmaceutical company's business planning, preparation for investment, and securing finance support; set up and currently leading team of >10
• Designed and delivered feasibility study for non-EU company’s start-up commercial operations; created savings of 40% over original plan
• Performed strategic review and identified qualified potential acquirers of US NASDAQ company
• Concluded out-licensing assignment for privately held US company; attractive up-front, milestones and royalty structure
• Strategic advisory and business development role introducing new technology relevant to major pharma R&D processes; initiated unique, first-in-class research alliance with NIH
• Managed sale of privately held US pharmaceutical / drug delivery company
• Analyzed and advised on commercialization options for potentially unique range of antimicrobial drug candidates
• Identified EU based outlicensing partners for US company’s lead products
• Identified late stage US pharmaceutical products and partner companies for UK specialty pharma company
• Designed and implemented commercial development plan for oncology product portfolio
• Advised North American public company on EU regulatory plan for new in-licensed product